Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Common Equity: 2013-2017

Historic Common Equity for Armata Pharmaceuticals (ARMP) over the last 5 years, with Dec 2017 value amounting to $7.7 million.

  • Armata Pharmaceuticals' Common Equity fell 9.85% to $8.8 million in Q3 2018 from the same period last year, while for Sep 2018 it was $8.8 million, marking a year-over-year decrease of 9.85%. This contributed to the annual value of $7.7 million for FY2017, which is 20.49% down from last year.
  • Latest data reveals that Armata Pharmaceuticals reported Common Equity of $7.7 million as of FY2017, which was down 20.49% from $9.7 million recorded in FY2016.
  • Over the past 5 years, Armata Pharmaceuticals' Common Equity peaked at $12.7 million during FY2015, and registered a low of -$22.6 million during FY2013.
  • Its 3-year average for Common Equity is $10.1 million, with a median of $9.7 million in 2016.
  • In the last 5 years, Armata Pharmaceuticals' Common Equity spiked by 269.92% in 2015 and then dropped by 23.53% in 2016.
  • Armata Pharmaceuticals' Common Equity (Yearly) stood at -$22.6 million in 2013, then spiked by 115.19% to $3.4 million in 2014, then spiked by 269.92% to $12.7 million in 2015, then decreased by 23.53% to $9.7 million in 2016, then dropped by 20.49% to $7.7 million in 2017.